What does this research mean for the field?

COVID-19 patients exhibit lower vitamin D levels, lower platelet counts, and higher platelet activation indices compared to Hepatitis C patients, which may contribute to thrombotic complications in COVID-19. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To compare the effect of vitamin D deficiency on platelet indices between COVID-19 and hepatitis C patients.

synapse

⌘+K

synapse

⌘+K

March 5, 2026Open Access

Comparative Study on the Effect of Vitamin D Deficiency on Platelet Indices in COVID-19 and Hepatitis C Patients; an Observational Comparative Study.

Key Points

To compare the effect of vitamin D deficiency on platelet indices between COVID-19 and hepatitis C patients.
Observational comparative study design
Assessment of vitamin D levels in both patient groups
Measurement of platelet counts and activation indices
COVID-19 patients had significantly lower vitamin D levels than hepatitis C patients
Platelet counts were lower in COVID-19 patients
Higher indices of platelet activation were observed in COVID-19 patients compared to HCV patients

Abstract

The results of this study showed that COVID-19 patients had lower vitamin D levels, lower PLT counts, and higher indices of platelet activation compared with HCV patients. These changes are associated with the severity of the inflammatory response in COVID-19 and could be part of the mechanisms that cause thrombotic complications in this disease.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Motaghi et al. (Sun,) studied this question.

synapsesocial.com/papers/69a91e12d6127c7a504c19b3 https://doi.org/https://doi.org/10.1002/hsr2.71945

Bookmark

View Full Paper